Arcellx, Inc. (ACLX)
114.39
+0.10
(+0.09%)
USD |
NASDAQ |
Mar 13, 16:00
114.36
-0.02
(-0.02%)
Pre-Market: 20:00
Arcellx Total Assets (Quarterly) : 603.99M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 59.02B |
| Eli Lilly & Co. | 112.48B |
| Johnson & Johnson | 199.21B |
| Merck & Co., Inc. | 136.87B |
| Amicus Therapeutics, Inc. | 949.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 201.64M |
| Shareholders Equity (Quarterly) | 402.35M |
| Debt to Equity Ratio | 0.129 |
| Current Ratio | 4.436 |
| Net Debt Paydown Yield | 0.07% |